Immunizations
-
Business
Moderna Stock Is Top S&P Performer After Miserable 2023. Why This Year Could Be Better.
Moderna stock was one of the worst performers in the S&P 500 last year as Covid-19 vaccine sales tumbled, but…
Read More » -
Business
Pfizer, Moderna, News Corp, Rite Aid, Charles Schwab, Tesla, and More Stock Market Movers
Stock futures traded mixed Monday as Wall Street prepared for a busy week of corporate earnings, with reports from Tesla and…
Read More » -
Business
Covid Booster Rollout Chaos Is Good News for Pfizer and Moderna
Text size Demand for Covid boosters has been higher than expected. Michael Nagle/Bloomberg The widely reported difficulties some Americans have…
Read More » -
Business
Pfizer stock rises on earnings beat, releases strong RSV data
Pfizer the stock rose after the company income statement beat Wall Street’s expectations. Pfizer reported $22.6 billion in revenue for…
Read More » -
Business
Pfizer earnings are Tuesday. What to see.
Pfizer is expected to report its earnings on Tuesday, a week and a half after an executive told investors the…
Read More » -
Business
Moderna shares deliver cancer vaccine news
Moderna stocks rise after Merck said it is exercising an option to research a personalized cancer vaccine with the Covid-19…
Read More » -
Business
Moderna shares deliver cancer vaccine news
Font size Merck and Moderna’s personalized cancer vaccine key data is expected to be released in the fourth quarter of…
Read More » -
Business
BA.5 omicron Covid booster could launch as soon as Labor Day Weekend
The Covid enhanced snapshot reformatted to target the omicron subvariables BA.4 and BA.5 received clearances from the Centers for Disease…
Read More » -
Business
Only a few weeks until specific Omicron boosters: A guide to eligibility
Newly updated Covid enhanced snapshots designed to target omicron’s BA.5 subvariable will be available within the next three weeks. That…
Read More »